ADA 2014 Report: National guidelines for lipids and blood pressure
National guidelines for lipids and blood pressure are likely to be a focus of attention at this year’s meeting of the American Diabetes Association.
National guidelines for lipids and blood pressure are likely to be a focus of attention at this year’s meeting of the American Diabetes Association.
Pan-European Survey reveals low levels of asthma control in Ireland. Irish respondents are experiencing asthma symptoms nearly 3 days a week. 48% of Irish people with asthma are… read more.
From 2006 to 2008, nearly 75 per cent of patients with diabetes living in Ontario did not receive all of the tests recommended to properly monitor their disease…. read more.
by Bruce Sylvester – Metformin therapy at 500 twice daily (BID) is not protective against heart failure in non-diabetic patients following a heart attack, researchers reported on March… read more.
by Bruce Sylvester – Emerging uses of FDA approved drugs – Eplerenone, a drug used to reduce the risk of death in patients with heart failure, shows significant… read more.
by Bruce Sylvester – Emerging uses of FDA-approved drugs – Treatment with acetazolamide plus a low-sodium weight-reduction diet for patients diagnosed with idiopathic intracranial hypertension (IIH)mand mild vision… read more.
In up to 85 percent of cases. “The substantial numbers of patients misdiagnosed and under diagnosed in this study is a cause for concern. It is important that… read more.
Enzyme’s role is to ‘throw away’ protein if it overstays its welcome during immune response. An enzyme that helps maintain immune system function by “throwing away” a specific… read more.
From the annual meeting of the British Transplantation Society in Glasgow by Marc J. Clancy. Since its establishment within the mainstream of clinical care, the technology of organ… read more.
by Gary Finnegan: New research reveals that patients in Sweden have a better chance of surviving a heart attack than their UK counterparts.
“Despite already being rolled-out in many countries, our study is the first to look at the feasibility of the Xpert test in a real-life clinical setting in southern… read more.
Exacerbation severity in patients with chronic obstructive pulmonary disease (COPD) can be reliably assessed with the COPD Assessment Test™ (CAT), according to a new study from the UK.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.